Haller Justin M, van der Meulen Marjolein C H, Olson Steven, Anderson Donald, Marsh J Lawrence, Working Zachary
Department of Orthopaedic Surgery, University of Utah, Salt Lake City, UT.
Nancy E and Peter C Meinig School of Biomedical Engineering Cornell University, Ithaca, NY.
OTA Int. 2023 May 4;6(2 Suppl):e232. doi: 10.1097/OI9.0000000000000232. eCollection 2023 May.
Posttraumatic osteoarthritis (PTOA) is a subset of osteoarthritis that occurs after joint injury and is associated with degradation of articular cartilage and subchondral bone. As compared with primary osteoarthritis, PTOA occurs in a time window initiated by a traumatic event resulting in damage to layers of joint structure and alterations in joint shape. As techniques in open reduction and internal fixation continue to mature, our success in preventing posttraumatic osteoarthritis has not kept pace. Advances in research in the subchondral bone, inflammatory response, and joint mechanics continue to open our understanding of this posttraumatic process. In addition, there are possibilities emerging as biological agents to therapeutically alter the progression of PTOA.
创伤后骨关节炎(PTOA)是骨关节炎的一个子集,发生在关节损伤后,与关节软骨和软骨下骨的退化有关。与原发性骨关节炎相比,PTOA发生在由创伤事件引发的时间窗口内,该创伤事件导致关节结构层受损和关节形状改变。随着切开复位内固定技术不断成熟,我们在预防创伤后骨关节炎方面的成效并未同步提升。软骨下骨、炎症反应和关节力学方面的研究进展不断拓展我们对这一创伤后过程的认识。此外,作为治疗性改变PTOA进展的生物制剂,也不断涌现出各种可能性。